publication date: Dec. 18, 2010

In this issue: 

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

Download (PDF 779KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.